The mental model

D&O insurance covers loss arising from claims that directors and officers breached their fiduciary duties to the company and its stakeholders. The breach is the trigger. The personal liability of the individual is the protected interest.

A director sits on a board. An officer holds a corporate office. Both owe legal duties to the corporation and its shareholders. When something goes wrong (a stock price drop, a transaction the board approved, a regulatory enforcement action, a bankruptcy), shareholders or the company itself may sue the directors and officers personally for damages. D&O is the policy that responds. Individuals get defense and indemnity. The corporation gets reimbursed when it indemnifies its officers. The corporation itself can also be a defendant in securities class actions and gets coverage for those claims directly. Three flavors of coverage, three "Sides," one policy.

Side A, Side B, Side C

The three coverage parts, or "Sides," correspond to three economic situations the policy addresses.

Why three Sides exist

The product evolved over decades. Side A came first because it was the original purpose: protect individuals when the corporation cannot or will not. Side B came when corporations realized they were spending real money indemnifying officers and wanted that reimbursed. Side C came in response to securities class actions that named the entity as a co-defendant alongside the officers. By the late 1990s entity coverage had become standard for public company D&O. The order Side A → Side B → Side C also matches the seniority of payment in some forms: Side A claims have priority access to the limit, ahead of corporate reimbursement.

Side A excess and difference-in-conditions (DIC)

Public companies typically build a tower. The primary D&O includes Sides A, B, and C. Above it sit excess D&O layers that follow form. Above those, sometimes, sits a Side A only excess or a Side A DIC layer that responds only when the underlying tower fails (insolvency, exhaustion, rescission). Side A DIC is sold as the directors' last line of defense for personal liability, and is increasingly purchased by independent directors as a condition of board service.

Duties of care, loyalty, good faith

The legal foundation of D&O is fiduciary duty. Directors and officers owe the corporation and its shareholders three principal duties:

• Duty of care. Act on an informed basis, with reasonable diligence. The classic "did the board do its homework" question. Most state statutes protect directors who acted with care under the business judgment rule, which presumes board decisions were properly made absent showing of self-dealing or bad faith.
• Duty of loyalty. Act in the corporation's interest, not the director's personal interest. The classic conflict-of-interest duty. Self-dealing transactions, usurped corporate opportunities, and undisclosed conflicts breach the duty of loyalty.
• Duty of good faith. Act with subjective good faith and not in conscious disregard of duties. This duty has been articulated as a separate strand by Delaware courts in cases like In re Caremark and Stone v. Ritter.

The business judgment rule

The most important defensive doctrine in D&O claims. Courts presume that directors acting in good faith, on an informed basis, and in the company's best interest are protected from liability for outcomes that turn out badly. The rule does not protect directors who failed to inform themselves, who had undisclosed conflicts, or who acted in bad faith. Underwriters look for board process: minutes that reflect deliberation, advice of counsel and bankers when appropriate, evidence the board actually considered alternatives.

Securities class actions

Public company D&O is dominated by securities class actions. Roughly 200-220 SCAs are filed each year in US federal courts. They are the single largest source of severity in the line.

The standard SCA pattern

1. A public company makes statements (in earnings releases, 10-Ks, 10-Qs, conference calls) about its business, products, or financial condition.
2. A negative event corrects the market's understanding (missed earnings, FDA warning letter, restatement, accounting scandal, regulatory action, drug failure, data breach).
3. The stock price drops sharply on the disclosure.
4. Plaintiff firms file complaints alleging the company and named officers made materially misleading statements or omissions during the class period, in violation of §10(b) of the Securities Exchange Act and Rule 10b-5.
5. The case is consolidated, lead plaintiff appointed, motion to dismiss filed.
6. If the motion to dismiss is denied, discovery and class certification follow. Most cases settle after class certification.

Severity drivers

Settlement values cluster around the size of the stock drop times the number of trading shares affected, with discounts for the strength of the merits and the company's ability to pay. The largest SCAs have settled for $1B+ (Worldcom, Cendant, Tyco). Median settlements run in the single-digit millions, but the right tail is heavy. Carriers price assuming a long-tail distribution.

Filing trends

Filing volume varies year to year but has been roughly stable in the ~210 range for several years. M&A "objection" suits inflated filings in the late 2010s and have declined since. Crypto, SPAC, and AI-related filings have been growth categories. Industry concentration tends toward technology, pharmaceuticals, financial services, and consumer products.

Derivative suits and book-entry

A derivative suit is brought by a shareholder on behalf of the corporation against directors and officers. Damages, if any, flow to the corporation, not to the shareholder. These suits proliferated post-Caremark and especially after high-profile corporate failures.

Why derivatives matter so much for D&O

State law (Delaware most prominently) bars corporations from indemnifying directors against derivative awards (a director cannot be made whole by the company they harmed). This means derivative judgments and many derivative settlements have to be paid by Side A coverage, the part of the policy with no retention and high priority. Carriers watch derivative exposure carefully, particularly in industries with active oversight liability (healthcare, food safety, pharma, increasingly cyber).

Books-and-records demands

Section 220 of the Delaware General Corporation Law lets shareholders demand books and records to investigate potential wrongdoing. A 220 demand often precedes a derivative suit. Underwriters increasingly ask about pending or recent 220 demands as a leading indicator of derivative claim exposure.

Public, private, and nonprofit D&O

The IPO and SPAC effect

2020 and 2021 produced an unprecedented wave of IPOs and SPAC de-SPAC transactions. The D&O underwriting of these deals tightened and re-priced sharply through 2022 as litigation followed the offerings into court. SPAC litigation patterns have been particularly distinctive: claims that target company projections were unsupported, that disclosures inadequately discussed risks, that conflicts among sponsors were not surfaced. Many SPACs that completed in 2021 have produced D&O claims that are still working through courts in 2025-2026.

The structural lessons:

• IPO companies face a one-time spike in D&O exposure (Section 11 strict liability) that tapers over the first 1-2 years post-IPO as the registration statement window closes.
• SPAC and de-SPAC transactions multiply the parties exposed (sponsor, target, combined entity) and create unique conflict issues.
• Run-off coverage on the pre-merger SPAC and the target is critical to ensure both legacy entities have tail protection.

The exclusions and the carve-backs

D&O exclusions are heavily negotiated. The form's exclusions are usually qualified by carve-backs that preserve coverage for the situations buyers care about most.

Standard exclusions and how they work

• Conduct exclusions. Excludes claims arising from deliberate fraud or personal profit obtained illegally, but coverage applies until there is a final, non-appealable adjudication that establishes the conduct. The "final adjudication" carve-back is critical: the policy defends through trial.
• Insured vs insured (IvI). Excludes claims by one insured against another, originally aimed at collusive lawsuits between former officers and the company. Modern D&O policies have many carve-backs: derivative suits, claims by a bankruptcy trustee, claims by a former director or officer who has been out of office for 2-3+ years, employment claims, whistleblower claims.
• Bodily injury / property damage. Goes on GL, not D&O. Carve-back for emotional distress in employment-related claims.
• Pollution. Standalone environmental coverage. D&O has carve-backs for shareholder derivative suits arising from pollution events.
• Prior acts / known matters. Excludes claims arising from prior acts before the retro date or from matters the insured knew about at policy inception.
• ERISA. Goes on fiduciary liability, separate product. D&O policies have standard ERISA exclusions.
• Professional services. If the company provides professional services, those go on E&O, not D&O. Tech companies, financial services firms, healthcare providers all need coordinated towers.

How underwriters evaluate the risk

1. Public vs private vs nonprofit. Different forms, different exposures.
2. Industry. Pharma, fintech, crypto, healthcare, energy each have characteristic claim profiles.
3. Financial condition. Solvency, going-concern qualifications, debt covenant compliance, cash runway. A distressed company is a bankruptcy waiting to happen and bankruptcy is a Side A trigger.
4. Stock price volatility (public companies). A volatile stock with frequent earnings surprises is an SCA waiting to happen.
5. Disclosure quality. 10-K and 10-Q risk factors, MD&A discussion, accounting policies, internal control narratives.
6. Recent corporate events. M&A activity, restatements, executive departures, regulatory inquiries, books-and-records demands, short reports.
7. Board composition and governance. Independence ratios, board committees, audit committee qualifications, whistleblower programs.
8. Tower structure and prior placement. Lead carrier, follow-form excess, Side A DIC.

Ideal submission pack

Where IDP earns its keep

D&O underwriting is heavily document-driven and the documents are dense: 10-Ks run hundreds of pages, proxy statements run dozens of densely formatted exhibits, the application has structured fields but warrant statements that need careful reading, prior loss data spans long-tail claim histories. Surfacing the right facts to the underwriter quickly is the high-leverage IDP application.

The D&O workflows where Indico shows up

• 10-K and 10-Q digestion. Pull risk factors, MD&A signals, going-concern language, internal control deficiencies, executive turnover from public filings.
• Application normalization. Map carrier-specific applications to a normalized account profile across the broker's submission pack.
• Application vs filing reconciliation. Cross-check application answers against the actual public filings to surface inconsistencies before they become claim disputes.
• Loss run analysis. SCA settlements, derivative settlements, regulatory matters. Long-tail claim lifecycles need careful normalization.
• News and litigation monitoring. Surface 220 demands, short reports, regulatory inquiries, and other leading indicators that may not appear on the application.